Veracyte, Inc. Common Stock (VCYT) News
Track canonical SquawkNews coverage tagged to VCYT, Veracyte, Inc. Common Stock. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 10 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 300 points on Friday. Shares of Apple Inc (NASDAQ: AAPL ) fell sharply in pre-market trading after the company posted results for th
EARNINGS | Jul 31, 2026, 12:03 PM UTC
H
VCYT PT Raised to $69
VCYT price target raised to $69
EQUITY | Jul 31, 2026, 11:52 AM UTC
L
VCYT sees FY revenue growth 14-15%
VCYT forecasts revenue growth
EARNINGS | Jul 30, 2026, 08:45 PM UTC
H
MYGN -29%, RBLX -11.6%, FLGT -10.7%, VCYT -9.8%, SYK -9.5%, ALHC -8.6%, COIN -6.5%, RDDT -5.8%, GSIT -5.3%, IR -3.1% after results
MYGN -29%, RBLX -11.6%, FLGT -10.7%, VCYT -9.8%, SYK -9.5%, ALHC -8.6%, COIN -6.5%, RDDT -5.8%, GSIT -5.3%, IR -3.1% after results
EARNINGS | Jul 30, 2026, 08:15 PM UTC
L
VCYT Veracyte RESULTS: Q2, Q2 REV $150.3M vs. EST $144.6M, Q2 ADJ operating expenses $70M, Q2 Net Income $25.5M, Q2 gross margin 72%, Veracy
VCYT Veracyte RESULTS: Q2, Q2 REV $150.3M vs. EST $144.6M, Q2 ADJ operating expenses $70M, Q2 Net Income $25.5M, Q2 gross margin 72%, Veracyte Earnings Notes:, Outlook FY REV $590-596M vs. EST $586.4M
EARNINGS | Jul 30, 2026, 08:09 PM UTC
L
Veracyte Raises FY2026 Sales Guidance from $582.000M-$592.000M to $590.000M-$596.000M vs $586.445M Est
Veracyte (NASDAQ: VCYT ) raises FY2026 sales outlook from $582.000 million-$592.000 million to $590.000 million-$596.000 million vs $586.445 million estimate.
EARNINGS | Jul 30, 2026, 08:07 PM UTC
L
VCYT - Veracyte Announces Second Quarter 2026 Financial Results
VCYT - Veracyte Announces Second Quarter 2026 Financial Results
EARNINGS | Jul 30, 2026, 08:05 PM UTC
L
VCYT - Veracyte to Participate in Upcoming Investor Conferences
VCYT - Veracyte to Participate in Upcoming Investor Conferences
EQUITY | Jul 28, 2026, 08:06 PM UTC
L
VCYT Initiated Overweight W/$66.00 PT at Piper Sandler
VCYT Initiated Overweight W/$66.00 PT at Piper Sandler
EQUITY | Jul 15, 2026, 11:47 AM UTC
L
VCYT new Overweight W/ $66 PT @ Piper
VCYT new Overweight W/ $66 PT @ Piper
EQUITY | Jul 15, 2026, 11:26 AM UTC